Post-marketing Surveillance (Special Use-results Surveillance) on Use With Liraglutide (Victoza®)
Status:
Completed
Trial end date:
2017-06-16
Target enrollment:
Participant gender:
Summary
This trial is conducted in Asia. The aim of this trial is to evaluate safety and
effectiveness of Victoza® in patients with type 2 diabetes mellitus (T2DM) in combination
with antidiabetes agents other than sulfonylurea under post-marketing normal clinical
practice conditions.